|

A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease

RECRUITINGPhase 1Sponsored by Eli Lilly and Company
Actively Recruiting
PhasePhase 1
SponsorEli Lilly and Company
Started2025-10-14
Est. completion2028-01
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
Locations13 sites

Summary

The purpose of this study is to see how safe LY4405094 is and to see how much and how quickly LY4405094 gets into the bloodstream. For healthy participants, the study also looks at how much LY4405094 gets into the fluid around the brain and lasts up to 13 weeks and will include a 4-day stay in the Clinical Research Unit (CRU). For participants with Alzheimer's Disease, the study will also look at levels of a specific Alzheimer's-related protein in the brain and will last up to 25 weeks and will include a 3-day stay in the CRU.

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* Participants must meet eligibility criteria in the ATMP screening protocol before entry into the treatment study.

Exclusion Criteria:

* Have known allergies to LY4405094, related compounds (including remternetug), or any components of the formulation, including LY4405094.
* Have known allergic reactions to adhesive or hydrogels or a family history of adhesive skin allergies.

Conditions5

Alzheimer DiseaseAlzheimer's DiseaseAmyloidHealthy VolunteersPlaque, Amyloid

Interventions1

Locations13 sites

CenExel ACT
Anaheim, California, 92801
714-774-7777
Irvine Clinical Research
Irvine, California, 92614
949-753-1663
Collaborative Neuroscience Network - CNS
Los Alamitos, California, 90720
714-799-7799
Fortrea Clinical Research Unit
Daytona Beach, Florida, 32117
386-366-6400
K2 Medical Research - The Villages
Lady Lake, Florida, 32159
321-278-5590

Find trials near these locations

Related trials

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.